News
Carlos Alcaraz has been wearing nasal strips in some matches since last season. That's sparked an interest in the ...
Joe Walsh is the first Alzheimer's patient to be treated with an experimental nasal spray designed to reduce inflammation in ...
Market Overview: The Global Nasal Polyposis Drugs Market is expanding rapidly, owing to advances in biologic medicines, minimally invasive surgical procedures, and personalized medicine approaches.
Here’s how it would work: A nasal mRNA vaccine would be taken as a spray through the nose, coating the nasal passages. The cells in the nasal lining would use the vaccine’s instructions to ...
If you need eyedrops for itching, start out with Pataday. Like the Flonase spray, it used to be prescription-only but is now ...
The global inhalation and nasal spray generic drugs market is projected to have a moderate-paced CAGR of 8.96% during the forecast period. The current valuation of the inhalation and nasal spray ...
10d
South Africa Today on MSNLiveSpo® NAVAX Nasal-Spray Probiotics: A New Approach in Supporting the Treatment of Rhinosinusitis and Otitis MediaHANOI, VIETNAM – Media OutReach Newswire – 19 May 2025 – LiveSpo® NAVAX – a nasal-spray probiotic product developed by Vietnamese scientists – has recently been published in the high-ranking ...
From seasonal pollen to pet dander, understanding your allergies and the treatment options available is critical to finding effective relief.
The protective effect was enhanced by delivering the antibody in a nasal spray that disperses these molecules throughout the respiratory tract, where they stick to the slippery mucus lining to lie in ...
An NHS doctor has warned specific people against using nasal sprays, warning that doing so could induce "horrible" symptoms. Nasal decongestants are widely sought after for those needing respite ...
Certain people have been warned against using nasal sprays by an NHS doctor. According to the expert, doing so could result in some “horrible” symptoms. Nasal decongestants can be a much ...
An engineered IgM-based monoclonal antibody delivered via nasal spray provided strong protection to mice against lethal influenza A infection, including H1N1 and H3N2 strains.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results